Meta-analysis of heterogeneously reported trials assessing change from baseline

Statistics in Medicine

Volumn 24, Issue 24, 2005, Pages 3823-3844

  Abrams, Keith R ^a   Gillies, Clare L ^a   Lambert, Paul C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bayesian methods; Change from baseline; Correlation; Meta analysis; Standardized difference

Indexed keywords

ARTICLE; BARTHEL INDEX; BAYES THEOREM; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DIETARY INTAKE; FUNCTIONAL ASSESSMENT; HEALTH CARE DELIVERY; HUMAN; LONG TERM CARE; MATHEMATICAL COMPUTING; META ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; PROBABILITY; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STANDARDIZATION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

BAYES THEOREM; GREAT BRITAIN; HUMANS; HYPERTENSION; MODELS, STATISTICAL; MONITORING, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS; SELF CARE;

EID: 30944462144     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2423     Document Type: Article

References (48)

1. Egger M, Davey-Smith G, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edn). BMJ Books: London, 2001.
2. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. Wiley: Chichester, 2000.
3. Fleiss JL. The statistical basis of meta-analysis. Statistical Methods in Medical Research 1993; 2:121-145.
4. Thompson SG. Why sources of heterogeneity in meta-analyses should be investigated. British Medical Journal 1994; 309:1351-1355.
5. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology 2002; 55(1):86-94.
6. Abrams KR, Sanso B. Approximate Bayesian inference in random effects meta-analysis. Statistics in Medicine 1998; 17:201-218.
7. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Statistical Methods in Medical Research 2001; 10:277-303.
8. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Healthcare Evaluation. Wiley: Chichester, 2003.
9. Cooper NJ, Sutton AJ, Abrams KR, Turner D, Wailoo A. Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Economics 2004; 13(3):203-226.
10. Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Statistics in Medicine 1996; 15:619-629.
11. Spiegelhalter DJ, Thomas A, Best NG, Lunn D. WinBUGS User Manual. Version 1.4.1. MRC Biostatistics Unit: 2004.
12. Altman DG. Practical Statistics for Medical Research. Chapman & Hall: London, 1991.
13. Senn S. Statistical Issues in Drug Development. Wiley: Chichester, 1997.
14. Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study. BMC Medical Research Methodology 2001; 1:6 http://www.biomedcentral.com/1471-2288/1/6 [Accessed 01.07.05].
15. Follmann D, Elliot P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992; 45(7):769-773.
16. Abrams KR, Lambert PC, Sanso B, Shaw C, Marteau T. Meta-analysis of heterogeneously reported study results - a Bayesian approach. In Meta-Analysis in Medicine & Health Policy, Berry D, Stangl D (eds), Chapter 2. Marcel Dekker: New York, 2000; 29-63.
17. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomized trials. British Medical Journal 2004; 329:145.
18. Peet SM, Phelps K, Parker Sg, Lindesay JEB, Baker R, Jagger C, Gillies C, Abrams K, Wailoo A, Beverley C. A systematic review of models of delivery of health care to older people in long-term residential and nursing homes. Technical Report, Nuffield Community Care Studies Unit, University of Leicester, March 2004.
19. Beaton GH, Martorell R, Aronson KJ, Edmonston B, McCabe G, Ross AC, Harvey B. Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. ACC/SCN State of the Art Series Nutrition Policy, Discussion Paper, No. 13. Administrative Committee on Coordination - Sub-Committee on Nutrition, Geneva (ACC/SCN), 1993.
20. DuMouchel W. Meta-analysis for dose-response models. Statistics in Medicine 1995; 14(5-7):679-685.
21. Berry DA, Berry SM, McKellar, Pearson TA. Comparison of the dose-response relationship of 2 lipid lowering agents: a Bayesian meta-analysis. American Heart Journal 2003; 145:1036-1045.
22. Daniels MJ, Hughes MD. Meta-analysis for the evaluation of potential surrogate markers. Statistics in Medicine 1997; 16(17):1965-1982.
23. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA. Meta-analysis of multiple outcomes by regression with random effects. Statistics in Medicine 1998; 17(22):2537-2550.
24. Arends LR, Voko Z, Stijnen T. Combining multiple outcome measures in a meta-analysis: an application. Statistics in Medicine 2003; 22:1335-1353.
25. Nam IS, Mengersen K, Garthwaite P. Multivariate meta-analysis. Statistics in Medicine 2003; 22:2309-2333.
26. Thompson JR, Minelli C, Abrams KR, Tobin MD, Riley RD. Meta-analysis of genetic studies using Mendelian randomization - a multivariate approach. Statistics in Medicine 2005; 24(14):2241-2254.
27. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. British Medical Journal 2002; 325:628.
28. Bowling A. Measuring Disease. Open University Press: Buckingham, 1995.
29. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity abd combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edn), Egger M, Davey-Smith G, Altman DG (eds), Chapter 15. BMJ Books: London, 2001; 285-312.
30. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27(2):252-259.
31. Craig J, Young CA, Ennis M, Boggild M. A randomized controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74:1225-1230.
32. Wilson A, Parker H, Wynn A, Jagger C, Spiers N, Jones J, Parker G. Randomised controlled trial of effectiveness of hospital at home. British Medical Journal 1999; 319:1542-1546.
33. StataCorp. 2003. Stata Statistical Software: Release 8. StataCorp LP: College Station, TX.
34. DerSimonian RD, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7:177-188.
35. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 2005; 2(1): 1-19.
36. Bernardo JM, Smith AFM. Bayesian Theory. Chichester: Wiley, 1994.
37. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Statistics in Medicine 2005; 24:2401-2428.
38. DuMouchel W. Bayesian meta-analysis. In Statistical Methodology in the Pharmaceutical Sciences, Berry DA (ed.). Marcel Dekker: New York, 1990; 509-529.
39. Gould AL. Using prior findings to augment active-controlled trials and trials with small placebo groups. Drug Information Journal 1991; 25:369-380.
40. Hedges LV. Distribution theory for Glass's estimator of effect size and related estimators. Journal of Educational Statistics 1981; 6:107-128.
41. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian graphical modelling for random effects meta-analysis: a comparative study. Statistics in Medicine 1995; 14(24):2685-2699.
42. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Statistics in Medicine 1996; 15(24):2733-2750.
43. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Hency D, Burchill SA. Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. British Journal of Cancer 2003; 88(8):1191-1198.
44. Goldstein H, Yang M, Omar R, Turner R, Thompson SG. Meta-analysis using multilevel models with an application to the study of class size effects. Journal of the Royal Statistical Society, Series C 2000; 49(3):399.
45. Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Evaluation and the Health Professions 2002; 25(1):76-97.
46. Spiegelhalter DJ, Best NG. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Statistics in Medicine 2003; 22(23):3687-3709.
47. Prevost TC, Abrams KR, Jones DR. Hierarchical models in generalised synthesis of evidence - a breast cancer screening example. Statistics in Medicine 2000; 19(24):3359-3376.
48. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technology Assessment 2003, 7(27):1-173.